Immunitybio Inc (IBRX)

Investing Cash Flow

-$276.91M

TTM · Period ending: · USD

IBRX logo

IBRX Investing Cash Flow

Latest reported-$276.91M
IBRX TTM Cash from Investing (-$299.00K → -$276.91M)
High-resolution chart · PNG

IBRX investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Immunitybio Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-276,907,000
-185,580,000
-149,801,000
-183,540,000
62,853,000
27,505,000
-12,246,000
-19,831,000
-100,494,000
-57,608,000
-30,470,000
-51,613,000
-37,150,000
88,126,000
27,297,000
-91,611,000
-79,861,000
-186,044,000
-84,886,000
60,461,000
-6,746,000
-1,961,000
-19,812,000
-15,194,000
58,805,000
54,909,000
21,456,000
25,207,000
24,707,000
34,722,000
57,101,000
60,921,000
51,008,000
86,434,000
99,552,000
71,354,000
71,248,000
4,278,000
-113,672,000
-277,187,000
-284,714,000
-275,229,000
-175,224,000
-3,293,000
-2,855,000
-2,204,000
-299,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.